What is Parkinson's?

Answers to common questions and links to support resources...

About us

How are we closer to the cure this month?

In April 2020, a research group in Shanghai (China), demonstrated that by reducing levels of a single protein in one type of helper cell - the astrocytes - they were able to encourage astrocytes to become neurons. In addition, they found that in mouse models of Parkinson's, those converted astrocytes then went on to become dopamine neurons specifically.

Stopping disease progression

Research spotlight

Stopping dopamine neuron degeneration by preventing Alpha-synuclein redistribution

Professor Spillantini and the team at Cambridge university believe that reducing the clumps of alpha-synuclein and restoring normal distribution in nerve endings will reinstate the typical release of dopamine and normal communication between the neurons, thereby reducing the clinical symptoms of Parkinson’s.

Take part in research

PD Frontline Trial

A remote study offering online genetic testing for people with Parkinson’s.

Take a Survery

Fugit quidem aut rerum rem tempore occaecati consequatur.

Donate

Fugit quidem aut rerum rem tempore occaecati consequatur. Itaque ut ea aut eligendi ea laborum error. Molestiae repellat ab quas asperiores doloribus. Frequency of donation

Our story

Answers to common questions This text will introduce the Cure Parkinsons story and mission…

Our story

Advocate spotlight

Anders Leines, Norway

Fugit quidem aut rerum rem tempore occaecati consequatur. Itaque ut ea aut eligendi ea laborum molestiae repellat ab quas.

Dr Simon Stott

Learn More

Andrew Lees, F.R.C.P., FMedSci

Learn More

Anthony Temple

Learn More

Brian Fiske, Ph.D.

Learn More

Caroline Tanner, M.D., Ph.D., F.A.A.N.

Learn More

Charlie Ralph

Learn More

Dame Barbara Hay

Learn More

David Ashford-Jones

Learn More

David Devos, Ph.D.

Learn More

David Gwynne Evans
Finance Director
David Gwynne-Evans

Learn More

David Murray

Learn More

David Simon, M.D.

Learn More

David Sulzer, M.D.

Learn More

David Tyndall

Learn More

Dimitri Krainc, M.D.

Learn More

Dr Alan Whone

Learn More

Dr Camille Carroll

Learn More

Dr Heather Mortiboys

Learn More

Dr John Warren

Learn More

Dr Kevin McFarthing

Learn More

Dr Peter Fletcher

Learn More

Director of Research and Development
Dr Richard Wyse

Learn More

Deputy Director of Research
Dr Simon Stott

Learn More

Dr Tilo Kunath

Learn More

Flint Beal, M.D.

Learn More

Deputy CEO
Helen Matthews

Learn More

Howard Federoff, M.D., Ph.D.

Learn More

John Trojanowski, M.D.

Learn More

Karl Kieburtz, M.D., MPH

Learn More

Kerry Rock

Learn More

Lady Shelagh Nichols

Learn More

Lyndsey Isaacs

Learn More

Trustee
Lyndsey Isaacs

Learn More

Mark Mattson, Ph.D.

Learn More

Mark R. Cookson, Ph.D.

Learn More

2019 Fundraiser of the Year Award Winner
Maura Ward

Learn More

Michael Schwarzschild, M.D., Ph.D.

Learn More

Patrik Brundin, M.D., Ph.D. (Scientific Committee chair)

Learn More

Compliance Coordinator
Person 1

Learn More

Compliance Coordinator
Person 2

Learn More

Peter Berners-Price

Learn More

Chair, Cure Parkinson's Research Committee
Professor Alasdair Coles

Learn More

Professor Roger Barker

Learn More

Director of Fundraising and Marketing
Rick Lay

Learn More

Ted Dawson, M.D., Ph.D.

Learn More

Tim Greenamyre, M.D., Ph.D.

Learn More

Tom Folytnie, Ph.D.

Learn More

CEO
Will Cook
Prev
Next